Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients

Citations Over TimeTop 12% of 2003 papers

Abstract

Conventional histopathologic staging of primary colorectal cancers does not allow accurate prognostic stratification within a given tumour stage. Therefore, PCR-based assays are increasingly used to try to predict more accurately the likelihood of disease progression for the individual patient. Real-time reverse transcription PCR (RT-PCR) assays were used to detect and quantitate cytokeratin 20 (ck20), carcinoembryonic antigen (CEA) and guanylyl cyclase C (GCC) mRNA in 149 lymph nodes (LN) from 17 patients with benign disease and 302 LN from 42 patients with colorectal cancer who had curative (R0) resections. None of the markers were specific, with ck20, CEA and GCC mRNA detected in 47%, 89% and 13% of 149 LN, respectively, from patients with benign disease. The sensitivity of all 3 markers was very high, with mRNA detected in 93%, 100% and 97% of 30 histologically involved LN, respectively. There was significant overlap in the mRNA levels of all 3 markers between histologically involved and uninvolved LN. There was no association between mRNA levels and distant recurrence (median follow-up: 3.94 years, range 3.35-5.12). We conclude that the use of molecular techniques to detect occult disease in LN may suffer from the same limitations as conventional methods. Instead, accurate prognostic stratification requires careful assessment of the likely metastatic potential of the primary cancer.

Related Papers

• → Carcinoembryonic Antigen (CEA) Family(2000)3 cited
• → Pancreatic Oncofetal Antigen and Carcinoembryonic Antigen in Breast and Colon Carcinoma(1988)1 cited
• → Carcinoembryonic Antigen, α<sub>1</sub>-Fetoprotein, Ferritin and α<sub>2</sub>-Pregnancy Associated Glycoprotein in the Serum of Lung Cancer Patients and its Demonstration in Lung Tumor Tissues(1977)16 cited
• Oncofetal antigens. Increasing the specificity of the CEA radioimmunoassay.(1977)
• [Carcinoembryonic antigen (CEA) and non-oncological liver diseases (case report)].(1981)